Specific mutations of basal core promoter are associated with chronic liver disease in hepatitis B virus subgenotype D1 prevalent in Turkey

Microbiology and Immunology

Volumn 57, Issue 2, 2013, Pages 122-129

  Sunbul, Mustafa ^a   Sugiyama, Masaya ^b   Kurbanov, Fuat ^c   Leblebicioglu, Hakan ^a   Khan, Anis ^c   Elkady, Abeer ^c   Tanaka, Yasuhito ^c   Mizokami, Masashi ^b  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Basal core promoter; Genotype D; Hepatitis B virus; Turkey

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; AGED; ARTICLE; ASIA; BASAL CORE PROMOTER; BLOOD SAMPLING; CHRONIC LIVER DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE TRANSMISSION; DNA ISOLATION; EUROPE; FEMALE; GENE CLUSTER; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SIMILARITY; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHICAL VARIATION (SPECIES); HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PREVALENCE; PROGNOSIS; PROMOTER REGION; SEQUENCE ANALYSIS; SEROCONVERSION; TURKEY (REPUBLIC); UNINDEXED SEQUENCE; VIRAL GENETICS; VIRUS LOAD; VIRUS STRAIN;

ADOLESCENT; ADULT; AGED; FEMALE; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; MUTATION; PHYLOGENY; PREVALENCE; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; TURKEY; YOUNG ADULT;

EID: 84873723790     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/1348-0421.12011     Document Type: Article

References (32)

1. Chen D.S. (1993) From hepatitis to hepatoma: lessons from type B viral hepatitis. Science 262: 369-70.
2. Usuda S., Okamoto H., Iwanari H., Baba K., Tsuda F., Miyakawa Y., Mayumi M. (1999) Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product. J Virol Methods 80: 97-112.
3. Kao J.H., Chen D.S. (2003) Clinical relevance of hepatitis B virus genotypes Ba and Bj in Taiwan. Gastroenterology 125: 1916-7 (author reply 17-8).
4. Miyakawa Y., Mizokami M. (2003) Classifying hepatitis B virus genotypes. Intervirology 46: 329-38.
5. Kao J.H., Chen P.J., Lai M.Y., Chen D.S. (2003) Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 124: 327-34.
6. Takahashi K., Ohta Y., Kanai K., Akahane Y., Iwasa Y., Hino K., Ohno N., Yoshizawa H., Mishiro S. (1999) Clinical implications of mutations C-to-T1653 and T-to-C/A/G1753 of hepatitis B virus genotype C genome in chronic liver disease. Arch Virol 144: 1299-308.
7. Kurbanov F., Tanaka Y., Mizokami M. (2010) Geographical and genetic diversity of the human hepatitis B virus. Hepatol Res 40: 14-30.
8. Thakur V., Guptan R.C., Kazim S.N., Malhotra V., Sarin S.K. (2002) Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent. J Gastroenterol Hepatol 17: 165-70.
9. Gandhe S.S., Chadha M.S., Arankalle V.A. (2003) Hepatitis B virus genotypes and serotypes in western India: lack of clinical significance. J Med Virol 69: 324-30.
10. Yalcin K., Degertekin H., Alp M.N., Tekes S., Satici O., Budak T. (2003) Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: clinical significance and correlation with serological markers. Turk J Gastroenterol 14: 157-63.
11. Dienstag J.L. (2008) Hepatitis B virus infection. N Engl J Med 359: 1486-500.
12. Ganem D., Prince A.M. (2004) Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 350: 1118-29.
13. Sugauchi F., Mizokami M., Orito E., Ohno T., Kato H., Suzuki S., Kimura Y., Ueda R., Butterworth L.A., Cooksley W.G. (2001) A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. J Gen Virol 82: 883-92.
14. Tamura K., Dudley J., Nei M., Kumar S. (2007) MEG A4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-9.
15. Abe A., Inoue K., Tanaka T., Kato J., Kajiyama N., Kawaguchi R., Tanaka S., Yoshiba M., Kohara M. (1999) Quantitation of hepatitis B virus genomic DNA by real-time detection PCR. J Clin Microbiol 37: 2899-903.
16. Tanaka Y., Hasegawa I., Kato T., Orito E., Hirashima N., Acharya S.K., Gish R.G., Kramvis A., Kew M.C., Yoshihara N., Shrestha S.M., Khan M., Miyakawa Y., Mizokami M. (2004) A case-control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D. Hepatology 40: 747-55.
17. Chen C.H., Lee C.M., Lu S.N., Changchien C.S., Eng H.L., Huang C.M., Wang J.H., Hung C.H., Hu T.H. (2005) Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan. J Clin Microbiol 43: 6000-6.
18. Khan A., Tanaka Y., Saito H., Ebinuma H., Sekiguchi H., Iwama H., Wakabayashi G., Kamiya T., Kurbanov F., Elkady A., Mizokami M. (2008) Transmission of hepatitis B virus (HBV) genotypes among Japanese immigrants and natives in Bolivia. Virus Res 132: 174-80.
19. Oyunsuren T., Kurbanov F., Tanaka Y., Elkady A., Sanduijav R., Khajidsuren O., Dagvadorj B., Mizokami M. (2006) High frequency of hepatocellular carcinoma in Mongolia; association with mono-, or co-infection with hepatitis C, B, and delta viruses. J Med Virol 78: 1688-95.
20. Tsatsralt-Od B., Takahashi M., Nishizawa T., Endo K., Inoue J., Okamoto H. (2005) High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia. J Med Virol 77: 491-9.
21. Elkady A., Tanaka Y., Kurbanov F., Oynsuren T., Mizokami M. (2008) Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia. J Gastroenterol Hepatol 23: 474-81.
22. Sendi H., Mehrab-Mohseni M., Zali M.R., Norder H., Magnius L.O. (2005) T1764G1766 core promoter double mutants are restricted to Hepatitis B virus strains with an A1757 and are common in genotype D. J Gen Virol 86: 2451-8.
23. Mizokami M., Orito E., Ohba K., Ikeo K., Lau J.Y., Gojobori T. (1997) Constrained evolution with respect to gene overlap of hepatitis B virus. J Mol Evol 44 (Suppl 1): S83-90.
24. Aye T.T., Uchida T., Becker S.O., Hirashima M., Shikata T., Komine F., Moriyama M., Arakawa Y., Mima S., Mizokami M., Lau J.Y.N. (1994) Variations of hepatitis B virus precore/core gene sequence in acute and fulminant hepatitis B. Dig Dis Sci 39: 1281-7.
25. Kramvis A., Arakawa K., Yu M.C., Nogueira R., Stram D.O., Kew M.C. (2008) Relationship of serological subtype, basic core promoter and precore mutations to genotypes/subgenotypes of hepatitis B virus. J Med Virol 80: 27-46.
26. Sugiyama M., Tanaka Y., Kato T., Orito E., Ito K., Acharya S.K., Gish R.G., Kramvis A., Shimada T., Izumi N., Kaito M., Miyakawa Y., Mizokami M. (2006) Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology 44: 915-24.
27. Ozasa A., Tanaka Y., Orito E., Sugiyama M., Kang J.H., Hige S., Kuramitsu T., Suzuki K., Tanaka E., Okada S., Tokita H., Asahina Y., Inoue K., Kakumu S., Okanoue T., Murawaki Y., Hino K., Onji M., Yatsuhashi H., Sakugawa H., Miyakawa Y., Ueda R., Mizokami M. (2006) Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology 44: 326-34.
28. Sugiyama M., Tanaka Y., Kurbanov F., Maruyama I., Shimada T., Takahashi S., Shirai T., Hino K., Sakaida I., Mizokami M. (2009) Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes. Gastroenterology 136: 652-62 e3.
29. Sugiyama M., Tanaka Y., Kurbanov F., Nakayama N., Mochida S., Mizokami M. (2007) Influences on hepatitis B virus replication by a naturally occurring mutation in the core gene. Virology 365: 285-91.
30. Tanaka Y., Kurbanov F., Mano S., Orito E., Vargas V., Esteban J.I., Yuen M.F., Lai C.L., Kramvis A., Kew M.C., Smuts H.E., Netesov S.V., Alter H.J., Mizokami M. (2006) Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. Gastroenterology 130: 703-14.
31. Ding X., Park Y.N., Taltavull T.C., Thung S.N., Jin X., Jin Y., Trung N.S., Edamoto Y., Sata T., Abe K. (2003) Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries. Jpn J Infect Dis 56: 12-8.
32. Zhang H., Zhai Y., Hu Z., Wu C., Qian J., Jia W., Ma F., Huang W., Yu L., Yue W., Wang Z., Li P., Zhang Y., Liang R., Wei Z., Cui Y., Xie W., Cai M., Yu X., Yuan Y., Xia X., Zhang X., Yang H., Qiu W., Yang J., Gong F., Chen M., Shen H., Lin D., Zeng Y.X., He F., Zhou G. (2010) Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet 42: 755-8.